Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06907797 · ClinicalTrials.gov registry record · NA
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
A NA study of Leukemia and Acute Leukemia, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06907797 is a NA study of Leukemia and Acute Leukemia that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 75 participants, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06907797, a NA study of Leukemia and Acute Leukemia, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
Conditions Studied
Interventions
- BEHAVIORAL TRIAL Web-Based Application
Study Locations (1)
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06907797
The ClinicalTrials.gov registry entry for NCT06907797 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 487-participant average among 233 other Leukemia trials with a reported enrollment target (85% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Leukemia appearing as the primary indexed condition, and to 1 intervention - of which TRIAL Web-Based Application is the first listed.
NCT06907797 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06907797 about?
NCT06907797 is a clinical study titled "Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing". This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.
What is the current status of trial NCT06907797?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-04-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06907797 study?
This clinical trial studies the following conditions: Leukemia, Acute Leukemia.
What interventions are being tested in trial NCT06907797?
The interventions under investigation include: TRIAL Web-Based Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT06907797?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06907797 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
RECRUITING · NA
-
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
RECRUITING · NA
-
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
RECRUITING · NA
-
HEME Home Transfusion Program
RECRUITING · NA
-
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.